257 related articles for article (PubMed ID: 25003230)
1. Engraftment and lineage potential of adult hematopoietic stem and progenitor cells is compromised following short-term culture in the presence of an aryl hydrocarbon receptor antagonist.
Gu A; Torres-Coronado M; Tran CA; Vu H; Epps EW; Chung J; Gonzalez N; Blanchard S; DiGiusto DL
Hum Gene Ther Methods; 2014 Aug; 25(4):221-31. PubMed ID: 25003230
[TBL] [Abstract][Full Text] [Related]
2. Wnt3a protein reduces growth factor-driven expansion of human hematopoietic stem and progenitor cells in serum-free cultures.
Duinhouwer LE; Tüysüz N; Rombouts EW; Ter Borg MN; Mastrobattista E; Spanholtz J; Cornelissen JJ; Ten Berge D; Braakman E
PLoS One; 2015; 10(3):e0119086. PubMed ID: 25807521
[TBL] [Abstract][Full Text] [Related]
3. Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source.
Hess NJ; Lindner PN; Vazquez J; Grindel S; Hudson AW; Stanic AK; Ikeda A; Hematti P; Gumperz JE
Front Immunol; 2020; 11():573406. PubMed ID: 33193358
[TBL] [Abstract][Full Text] [Related]
4. Ex Vivo Expansion of CD34
Bari S; Zhong Q; Fan X; Poon Z; Lim AST; Lim TH; Dighe N; Li S; Chiu GNC; Chai CLL; Hwang WYK
Stem Cells Transl Med; 2018 May; 7(5):376-393. PubMed ID: 29392885
[TBL] [Abstract][Full Text] [Related]
5. Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice.
Milazzo L; Vulcano F; Barca A; Macioce G; Paldino E; Rossi S; Ciccarelli C; Hassan HJ; Giampaolo A
Eur J Haematol; 2014 Nov; 93(5):384-91. PubMed ID: 24797266
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of ex vivo expanded CD34
Zhang Y; Shen B; Guan X; Qin M; Ren Z; Ma Y; Dai W; Ding X; Jiang Y
Stem Cell Res Ther; 2019 Jun; 10(1):173. PubMed ID: 31196160
[TBL] [Abstract][Full Text] [Related]
7. Study of stem cell homing & self-renewal marker gene profile of
Kode J; Khattry N; Bakshi A; Amrutkar V; Bagal B; Karandikar R; Rane P; Fujii N; Chiplunkar S
Indian J Med Res; 2017 Jul; 146(1):56-70. PubMed ID: 29168461
[TBL] [Abstract][Full Text] [Related]
8. Targeting the aryl hydrocarbon receptor nuclear translocator complex with DMOG and Stemregenin 1 improves primitive hematopoietic stem cell expansion.
Jackson CS; Durandt C; Janse van Rensburg I; Praloran V; Brunet de la Grange P; Pepper MS
Stem Cell Res; 2017 May; 21():124-131. PubMed ID: 28445828
[TBL] [Abstract][Full Text] [Related]
9. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
Hogan CJ; Shpall EJ; McNiece I; Keller G
Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential.
McNiece IK; Almeida-Porada G; Shpall EJ; Zanjani E
Exp Hematol; 2002 Jun; 30(6):612-6. PubMed ID: 12063029
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
[TBL] [Abstract][Full Text] [Related]
12. T-cell potential of human adult and cord blood hemopoietic stem cells expanded with the use of aryl hydrocarbon receptor antagonists.
Carlin SM; Ma DD; Moore JJ
Cytotherapy; 2013 Feb; 15(2):224-30. PubMed ID: 23321333
[TBL] [Abstract][Full Text] [Related]
13. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.
Lam AC; Li K; Zhang XB; Li CK; Fok TF; Chang AM; James AE; Tsang KS; Yuen PM
Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic potential of cryopreserved and ex vivo manipulated umbilical cord blood progenitor cells evaluated in vitro and in vivo.
DiGiusto DL; Lee R; Moon J; Moss K; O'Toole T; Voytovich A; Webster D; Mule JJ
Blood; 1996 Feb; 87(4):1261-71. PubMed ID: 8608214
[TBL] [Abstract][Full Text] [Related]
15. Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood.
Tanavde VM; Malehorn MT; Lumkul R; Gao Z; Wingard J; Garrett ES; Civin CI
Exp Hematol; 2002 Jul; 30(7):816-23. PubMed ID: 12135681
[TBL] [Abstract][Full Text] [Related]
16. Expansion and homing of umbilical cord blood hematopoietic stem and progenitor cells for clinical transplantation.
Bari S; Seah KK; Poon Z; Cheung AM; Fan X; Ong SY; Li S; Koh LP; Hwang WY
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1008-19. PubMed ID: 25555449
[TBL] [Abstract][Full Text] [Related]
17. Advances in umbilical cord blood stem cell expansion and clinical translation.
Pineault N; Abu-Khader A
Exp Hematol; 2015 Jul; 43(7):498-513. PubMed ID: 25970610
[TBL] [Abstract][Full Text] [Related]
18. Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis.
Sun H; Tsai Y; Nowak I; Liesveld J; Chen Y
Stem Cell Res; 2012 Sep; 9(2):77-86. PubMed ID: 22683680
[TBL] [Abstract][Full Text] [Related]
19. Non-fucosylated CB CD34
Robinson SN; Thomas MW; Simmons PJ; Lu J; Yang H; Javni JA; Shpall EJ; Zweidler-Mckay PA
Cytotherapy; 2017 Feb; 19(2):285-292. PubMed ID: 27919572
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood.
Huang GP; Pan ZJ; Jia BB; Zheng Q; Xie CG; Gu JH; McNiece IK; Wang JF
Cell Transplant; 2007; 16(6):579-85. PubMed ID: 17912949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
